179 related articles for article (PubMed ID: 16618741)
21. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
Schwock J; Pham NA; Cao MP; Hedley DW
Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
[TBL] [Abstract][Full Text] [Related]
22. Induction of cell stress through gene transfer of an engineered heat shock transcription factor enhances tumor immunogenicity.
Gough MJ; Melcher AA; Crittenden MR; Sanchez-Perez L; Voellmy R; Vile RG
Gene Ther; 2004 Jul; 11(13):1099-104. PubMed ID: 15103319
[TBL] [Abstract][Full Text] [Related]
23. Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70.
Phillips PA; Dudeja V; McCarroll JA; Borja-Cacho D; Dawra RK; Grizzle WE; Vickers SM; Saluja AK
Cancer Res; 2007 Oct; 67(19):9407-16. PubMed ID: 17909050
[TBL] [Abstract][Full Text] [Related]
24. Skewing the T-cell repertoire by combined DNA vaccination, host conditioning, and adoptive transfer.
Jorritsma A; Bins AD; Schumacher TN; Haanen JB
Cancer Res; 2008 Apr; 68(7):2455-62. PubMed ID: 18381454
[TBL] [Abstract][Full Text] [Related]
25. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.
Huerta S; Heinzerling JH; Anguiano-Hernandez YM; Huerta-Yepez S; Lin J; Chen D; Bonavida B; Livingston EH
J Surg Res; 2007 Sep; 142(1):184-94. PubMed ID: 17603079
[TBL] [Abstract][Full Text] [Related]
26. A novel anticancer approach: SEA-anchored tumor cells expressing heat shock protein 70 onto the surface elicit strong anticancer efficacy.
Huang C; Yu H; Wang Q; Yang G; Ma W; Xia D; Chen X; Yi P; Shen F; Zheng H; Cao X
Immunol Lett; 2005 Oct; 101(1):71-80. PubMed ID: 15908014
[TBL] [Abstract][Full Text] [Related]
27. Potent triazolothione inhibitor of heat-shock protein-90.
Feldman RI; Mintzer B; Zhu D; Wu JM; Biroc SL; Yuan S; Emayan K; Chang Z; Chen D; Arnaiz DO; Bryant J; Ge XS; Whitlow M; Adler M; Polokoff MA; Li WW; Ferrer M; Sato T; Gu JM; Shen J; Tseng JL; Dinter H; Buckman B
Chem Biol Drug Des; 2009 Jul; 74(1):43-50. PubMed ID: 19519743
[TBL] [Abstract][Full Text] [Related]
28. Enhanced T-cell immunity induced by dendritic cells with phagocytosis of heat shock protein 70 gene-transfected tumor cells in early phase of apoptosis.
Chan T; Chen Z; Hao S; Xu S; Yuan J; Saxena A; Qureshi M; Zheng C; Xiang J
Cancer Gene Ther; 2007 Apr; 14(4):409-20. PubMed ID: 17235354
[TBL] [Abstract][Full Text] [Related]
29. Acute acidification or amiloride treatment suppresses the ability of Hsp70 to inhibit heat-induced apoptosis.
Lachapelle G; Radicioni SM; Stankiewicz AR; Mosser DD
Apoptosis; 2007 Aug; 12(8):1479-88. PubMed ID: 17431790
[TBL] [Abstract][Full Text] [Related]
30. Heat-shock protein 90 (Hsp90) as a molecular target for therapy of gastrointestinal cancer.
Moser C; Lang SA; Stoeltzing O
Anticancer Res; 2009 Jun; 29(6):2031-42. PubMed ID: 19528462
[TBL] [Abstract][Full Text] [Related]
31. Modified HPV16 E7/HSP70 DNA vaccine with high safety and enhanced cellular immunity represses murine lung metastatic tumors with downregulated expression of MHC class I molecules.
Li H; Ou X; Xiong J
Gynecol Oncol; 2007 Mar; 104(3):564-71. PubMed ID: 17081598
[TBL] [Abstract][Full Text] [Related]
32. Heat shock protein-antigen fusions lose their enhanced immunostimulatory capacity after endotoxin depletion.
Marincek BC; Kühnle MC; Srokowski C; Schild H; Hämmerling G; Momburg F
Mol Immunol; 2008 Nov; 46(1):181-91. PubMed ID: 18804283
[TBL] [Abstract][Full Text] [Related]
33. Immune expression and inhibition of heat shock protein 90 in uveal melanoma.
Faingold D; Marshall JC; Antecka E; Di Cesare S; Odashiro AN; Bakalian S; Fernandes BF; Burnier MN
Clin Cancer Res; 2008 Feb; 14(3):847-55. PubMed ID: 18245548
[TBL] [Abstract][Full Text] [Related]
34. Additive viability-loss following hsp70/hsc70 double interference and Hsp90 inhibition in two breast cancer cell lines.
Håvik B; Bramham CR
Oncol Rep; 2007 Jun; 17(6):1501-10. PubMed ID: 17487411
[TBL] [Abstract][Full Text] [Related]
35. Nitric oxide boosts chemoimmunotherapy via inhibition of acid sphingomyelinase in a mouse model of melanoma.
Perrotta C; Bizzozero L; Falcone S; Rovere-Querini P; Prinetti A; Schuchman EH; Sonnino S; Manfredi AA; Clementi E
Cancer Res; 2007 Aug; 67(16):7559-64. PubMed ID: 17699758
[TBL] [Abstract][Full Text] [Related]
36. Heat Shock Protein 70 Prevents Hyperoxia-Induced Disruption of Lung Endothelial Barrier via Caspase-Dependent and AIF-Dependent Pathways.
Kondrikov D; Fulton D; Dong Z; Su Y
PLoS One; 2015; 10(6):e0129343. PubMed ID: 26066050
[TBL] [Abstract][Full Text] [Related]
37. In vitro combined modality treatment of prostate carcinoma cells with 17-(allylamino)-17-demethoxygeldanamycin and ionizing radiation.
Ochel HJ; Gademann G
Anticancer Res; 2006; 26(3A):2085-91. PubMed ID: 16827149
[TBL] [Abstract][Full Text] [Related]
38. Catalytically active Yersinia outer protein P induces cleavage of RIP and caspase-8 at the level of the DISC independently of death receptors in dendritic cells.
Gröbner S; Adkins I; Schulz S; Richter K; Borgmann S; Wesselborg S; Ruckdeschel K; Micheau O; Autenrieth IB
Apoptosis; 2007 Oct; 12(10):1813-25. PubMed ID: 17624595
[TBL] [Abstract][Full Text] [Related]
39. Peptides and aptamers targeting HSP70: a novel approach for anticancer chemotherapy.
Rérole AL; Gobbo J; De Thonel A; Schmitt E; Pais de Barros JP; Hammann A; Lanneau D; Fourmaux E; Demidov ON; Micheau O; Lagrost L; Colas P; Kroemer G; Garrido C
Cancer Res; 2011 Jan; 71(2):484-95. PubMed ID: 21224349
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic vaccination with dendritic cells pulsed with tumor-derived Hsp70 and a COX-2 inhibitor induces protective immunity against B16 melanoma.
Toomey D; Conroy H; Jarnicki AG; Higgins SC; Sutton C; Mills KH
Vaccine; 2008 Jun; 26(27-28):3540-9. PubMed ID: 18479787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
